Results 181 to 190 of about 1,199,725 (267)
Molecular Oncology, EarlyView.Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Cosmos: a survey of the general physical history of the universe
Alexander von Humboldt +1 more
openalex +2 more sources
Molecular Oncology, EarlyView.In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa +14 more
wiley +1 more source
Sirk: MATHEMATIK FÜR NATURWISSENSCHAFTLER/Hund: ATOM‐ UND QUANTENTHEORIE/Becker: THEORIE DER ELEKTRIZITÄT/Becker: STERNE UND STERNSYSTEME/Hoyle: THE NATURE OF THE UNIVERSE/Schober: DAS SEHEN/Herrmann‐Wagener: DIE OXYDKATHODE/ERGÄNZUNGEN UND BERICHTIGUNGEN [PDF]
, 1951 H. V. Sanden +6 more
openalex +1 more source
Viewpoint: Artificial intelligence or cosmogenic intelligence? [PDF]
Biomater TranslXia Z.
europepmc +1 more source
The IFNγ‐CIITA‐MHC II axis modulates melanoma cell susceptibility to NK‐cell‐mediated cytotoxicity
Molecular Oncology, EarlyView.Natural killer (NK) cells play a central role in anti‐melanoma immunity. However, melanoma cells adapt during co‐culture by upregulating CIITA and MHC II in response to interferon gamma (IFNγ), thereby evading NK‐cell lysis. Blocking IFNγ signaling or treatment with dimethyl fumarate/simvastatin counteracts this immune escape and maintains NK‐cell ...
Lena C. M. Krause +6 more
wiley +1 more source
Maximum Entropy Estimates of Hubble Constant from Planck Measurements. [PDF]
Entropy (Basel)Knobles DP, Westling MF.
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Molecular Oncology, EarlyView.Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source